A new target for cancer drug development




Harvard Stem Cell Institute researchers have identified in the most aggressive forms of cancer a gene known to regulate embryonic stem cell self-renewal, beginning a creative search for a drug that can block its activity.

Fuente : http://www.eurekalert.org/pub_releases/2013-06/hu-...

Lunes, 17 de Junio 2013
Jueves, 1 de Enero 1970
1

1 1
Otros artículos de esta sección